Ingredion anticipates $10.30-$10.90 2026 adjusted EPS while progressing Tate & Lyle deal with $130M run-rate synergies by 2030
This is a summary aggregated from Seeking Alpha. Read the complete article on the original site:
Read full article at Seeking Alpha